Home

/

News

/

Research

Peter Crowley secures the SSPC Director’s Award for Research Article of the Year

September 12, 2022

Congratulations to Prof. Peter Crowley, University of Galway on receiving SSPC’s Director’s Award for Research Article of the Year 2021 for the publication – ‘Facile Fabrication of Protein-Macrocycle Frameworks’, by Kiefer O. Ramberg, Sylvain Engilberge, Tomasz Skorek and Peter B. Crowley in the Journal of the American Chemical Society.

In their article Peter Crowley and co-workers demonstrated how protein frameworks can be engineered by using a commercially-available molecule called sulfonato-calix[8]arene. This cyclic molecule can stick to the protein surface and act like a scaffold to bind other proteins, resulting in assembly. Different techniques including X-ray crystallography and NMR spectroscopy were used to demonstrate protein – calixarene binding and assembly. These protein – calixarene frameworks may have applications in biomaterial design and fabrication.

Peter Crowley is professor of protein chemistry in the School of Biological and Chemical Sciences at the University of Galway, and a funded investigator in SSPC’s Manufacturing theme. He is a graduate of University College Dublin and Leiden University, the Netherlands.

His research interests include molecular recognition, protein assembly, structural biology and protein-based materials.

Ramberg, K. O., Engilberge, S., Skorek, T. & Crowley, P. B. ‘Facile Fabrication of Protein-Macrocycle Frameworks’ J. Am. Chem. Soc. 2021, 43, 1896–1907.

More news

Insights into Flow and Continuous Systems in Pharmaceutical Manufacturing: Challenges and Opportunities

Insights into Flow and Continuous Systems in Pharmaceutical Manufacturing: Challenges and Opportunities

Ireland’s pharmaceutical sector has transformed over the past 50 years, from an API manufacturing base to a global hub for high value activities including process R&D, formulation, bioprocessing, and biotechnology. A major recent shift has been the adoption of continuous flow technology, offering improvements in safety, efficiency, and flexibility. While integrating flow into a highly regulated environment is complex, Ireland’s ecosystem, multinational API sites, CDMOs, and innovative indigenous companies, has successfully advanced large scale API and RSM manufacture through strong collaboration with regulatory agencies. This commentary highlights key factors enabling this transition and the current state of continuous flow in API/RSM production.

https://doi.org/10.1021/acs.oprd.5c00309

Partners: Eli Lilly, MSD, Pfizer, JnJ, sk biotek, apc, almac, WAB, arran chemical, UCC, UCD, UL.

read more